Back to search
FDAFDA · Food and drugs·Recall number Z-2918-2018

Immunoscan CCPlus test kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative and semiquantitative determination of IgG antibodies to Cyclic Citrullinated Peptides (CCP) in human sera.

Published August 29, 2018 · Recall initiated: February 14, 2016

Summary

FDA records medical device Class II recall Z-2918-2018, published August 29, 2018 and initiated February 14, 2016. Recalling firm: Euro Diagnostica AB; Status: Terminated; Reported quantity: 25 kits (US only); Lot: Lot # RS 3092, SS 1737. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Decreasing performance overtime.

What to do

Voluntary: Firm initiated · Other

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Euro Diagnostica AB
Distributor
Minnesota and Texas Foreign: Iran
Lot
Lot # RS 3092, SS 1737
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was Immunoscan CCPlus test kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative and semiquantitative determination of IgG antibodies to Cyclic Citrullinated Peptides (CCP) in human sera. recalled?

Yes. FDA published recall Z-2918-2018 on August 29, 2018. Reported hazard: Decreasing performance overtime.

What should I do if I have this product?

Voluntary: Firm initiated · Other